Lipid-regulating drugs

US researchers say statins may speed up Parkinson’s in susceptible patients

A new study suggests that the use of statins is associated with a higher risk of developing symptoms of Parkinson’s disease.…

Phase III trial will investigate potential of statins as treatment for multiple sclerosis

The potential of the cheap cholesterol-lowering drug simvastatin as a treatment option for multiple sclerosis is to be investigated in a phase III trial involving more than 1,000 patients.…

Statins benefit patients with hepatitis B and C-related cirrhosis

Statins may benefit patients with cirrhosis of the liver caused by the Hepatitis B (HBV) or Hepatitis C (HCV) virus, according to the results of a Taiwan study published in Hepatology [1] (online, 20 March 2017). Researchers found that cirrhotic patients who took statins sho…

Stem-cell screening finds statin alternative for hypercholesterolaemia

Researchers discover a stem-cell based approach that may help identify new treatments for inherited liver diseases…

Adherence to high intensity statins drops off for heart attack patients

Better insurance for drug costs, more specialist visits and taking part in cardiac rehabilitation could improve adherence to recommended statin treatment, researchers believe.…

Stroke patients may need more help with statins management

Health professionals need to do more to address concerns about side effects in patients prescribed statins after a stroke, research suggests.…

Statins associated with increased risk of diabetes in older women

Clinical studies have shown that statins can increase the risk of new-onset diabetes. However, little is known about the risks in older women.…

PCSK9 inhibitor evolocumab cuts risk of cardiovascular events, study results show

New mantra should be to get cholesterol as low as possible, researchers conclude.…

No survival benefit from adding statins to lung cancer treatment

Adding pravastatin to platinum-based chemotherapy offered no benefit to survival compared with placebo, researchers report.…

Cholesterol-lowering statin therapy for healthy people is not as simple as ‘yes’ or ‘no’

Recent reports of large trials extolling the virtues of statins have led many to believe that low-risk patients should take them, but an examination of the evidence provides food for thought.…